Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis

Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis

Aim: This study aimed to evaluate the clinical significance of fecal calprotectin (FC) in assessment of ulcerative colitis (UC) patients' endoscopic patterns and clinical manifestation.Methods: A total of 143 UC patients who received colonoscopy and 108 controls were included. After providing s...

Full description

Bibliographic Details
Main Authors:	Fang Chen, Yue Hu, Yi-Hong Fan, Bin Lv
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Medicine
Subjects:	biomarkers ulcerative colitis fecal calprotectin mucosal healing clinical value
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.679264/full

Similar Items

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
by: Edyta Szymańska, et al.
Published: (2020-12-01)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
by: Dong Ju Kim, et al.
Published: (2018-10-01)

Role of Fecal Calprotectin as a Noninvasive Indicator for Ulcerative Colitis Disease Activity
by: Nakov Radislav V., et al.
Published: (2019-06-01)

Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis
by: Elham A Hassan, et al.
Published: (2017-01-01)

Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study
by: Onişor Danusia, et al.
Published: (2018-07-01)

Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-06-01)

Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis
by: Sun-Ho Lee, et al.
Published: (2017-10-01)

Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin
by: Juan María Vázquez-Morón, et al.

Utility of fecal calprotectin as a discriminative biomarker between ulcerative colitis and irritable bowel syndrome and its ability to be used for the assessment of the remission stage of ulcerative colitis
by: Hossam M Elsaadany, et al.
Published: (2016-01-01)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
by: Hamid Kalantari, et al.
Published: (2015-01-01)

The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces
by: Sakiko Hiraoka, et al.
Published: (2019-04-01)

Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring
by: Shu-Chen Wei, et al.
Published: (2018-10-01)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
by: Jun Kato, et al.
Published: (2016-01-01)

Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study
by: Nobuhiro Ueno, et al.
Published: (2021-08-01)

Relationship between mucosal healing by tacrolimus and relapse of refractory ulcerative colitis: a retrospective study
by: Ayumi Ito, et al.
Published: (2020-06-01)

The predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing
by: Takuya Yoshino, et al.
Published: (2016-01-01)

Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
by: Fernando Magro, et al.
Published: (2017-07-01)

Extent of disease affects the usefulness of fecal biomarkers in ulcerative colitis
by: Akihito Sakuraba, et al.
Published: (2021-05-01)

Association between platelet count and mucosal healing in Japanese patients with ulcerative colitis: a cross-sectional study
by: Shinya Furukawa, et al.
Published: (2020-11-01)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
by: von Arnim U, et al.
Published: (2016-04-01)

Fecal calprotectin and microbiota of the gut
by: V. G. Gorokhova, et al.
Published: (2016-07-01)

Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis
by: Hsu-Heng Yen, et al.
Published: (2020-07-01)

Fecal B-cell-activating factor as a new noninvasive marker in the evaluation of ulcerative colitis Egyptian patients: a comparative cross-sectional study
by: Hany A Hussein, et al.
Published: (2019-01-01)

Rational Use of Fecal Calprotectin in Irritable Bowel Syndrome and Inflammatory Bowel Disease
by: Roberto Catanzaro, et al.
Published: (2021-05-01)

Fecal calprotectin in the differential diagnosis of acute intestinal infections
by: E. D. Vlkova, et al.
Published: (2018-07-01)

Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients
by: R. Vicente-Steijn, et al.
Published: (2020-08-01)

Fecal Calprotectin in Inflammatory Bowel Disease
by: Jun Lee
Published: (2016-05-01)

Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials
by: Toshifumi Hibi, et al.
Published: (2020-01-01)

Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study
by: Shiro Nakamura, et al.
Published: (2018-10-01)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
by: Corina Silvia Pop, et al.
Published: (2021-12-01)

Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease
by: Fang Liu, et al.
Published: (2020-12-01)

The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
by: Yujin Jeong, et al.
Published: (2021-01-01)

Fecal calprotectin concentration in neonatal necrotizing enterocolitis
by: Jung Min Yoon, et al.
Published: (2014-08-01)

Fecal calprotectin in inflammatory bowel disease
by: Walsham NE, et al.
Published: (2016-01-01)

The utility of fecal lactoferrin measurements in predicting disease activity of hospitalized patients with ulcerative colitis
by: Mandehr, Kellen Franklyn
Published: (2016)

Colitis in spondyloarthritis
by: Muhammed Hafis, et al.
Published: (2020-01-01)

Biomarkers in the management of ulcerative colitis: a brief review
by: Hussain, Shabnum, et al.
Published: (2011-01-01)

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
by: Mariusz A. Bromke, et al.
Published: (2021-05-01)

Value of fecal calprotectin in the diagnosis of chronic inflammatory bowel diseases in children
by: T.V. Yaroshevska, et al.
Published: (2018-03-01)

An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis
by: Manuel Ponce-Alonso, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_tr6i131qfcb9ajet1io92k9ei7